FDA Issues Emergency Use Authorization for Topical Spray to Prevent and Treat New World Screwworm in Multiple Species
On Mar. 10, 2026, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for…
-
-
Blood Test Predicts Dementia in Women as Many as 25 Years Before Symptoms Begin
On Mar. 10, 2026, researchers from the University of California San Diego have found that a novel blood-based…
-
WHO releases first-ever implementation handbook to accelerate country action on hepatitis elimination
On Mar. 10, 2026, the World Health Organization (WHO) released landmark Consolidated guidance and implementation handbook on hepatitis…
-
New Study Exposes Hidden Alzheimer’s “Hot Spots” in Rural Maryland and What They Reveal About America’s Growing Healthcare Divide
On Mar. 8, 2026, a new statewide spatial analysis of Alzheimer’s disease and related dementias (ADRD) has uncovered…
-
U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for Treatment of Adults with Psoriatic Arthritis
On Mar. 6, 2026, Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has approved…
-
Sumitomo Receives Approval for world’s first iPS cell‑derived regenerative medicine in Japan
On Mar. 6, 2026, Sumitomo Pharma announce it has obtained conditional and time‑limited approval in Japan for the…
-
Tubulin prevents toxic protein clumps in the brain, fighting back neurodegeneration
On Mar. 6, 2026, researchers at Baylor College of Medicine announced they have discovered a potential new strategy…
-
China approves Pfizer GLP-1 drug for weight loss
On Mar. 5, 2026, China has approved Pfizer’s GLP-1 treatment Xianweiying for long-term weight management in overweight or…
-
Study Shows Life forms can planet hop on asteroid debris—and survive
On Mar. 3, 2026, a Johns Hopkins university study shows major impacts could transport life between planets. Tiny…
-
Emerging cattle disease spreads to 60 Missouri counties
On Mar. 2, 2026, first reported two years ago, Theileria orientalis is moving westward, with no antibiotics on…
-
New microscope reveals living cells in unprecedented detail
On Mar. 2, 2026, Stanford scientists announced that a one-of-a-kind instrument can show cell structures interacting in real…
-
Novo Nordisk announces more than 400 million euro expansion in its manufacturing facility in Ireland
On Mar. 2, 2026, Novo Nordisk announced an investment of 432 million euro (approx. DKK 3.2 billion) in…
-
EMA recommends Moderna’s combined mRNA vaccine for protecting older adults against COVID-19 and flu
On Feb. 27, 2026, the European Medicines Agency (EMA) announced it’s recommending marketing authorization for mCombriax, Moderna’s combined…
-
Biotechnology | Disease | FDA
FDA approves Novo Nordisk’s Sogroya® as first and only once-weekly, long-acting growth hormone for three additional pediatric indications
On Feb. 27, 2026, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved three…
-
Study finds First-ever in-utero stem cell therapy for fetal spina bifida repair is safe
On Feb. 26, 2026, A University of California Davis Health research team has safely performed the world’s first spina…
-
Novartis settles with Henrietta Lacks’ estate over use of her ‘stolen’ cells to advance medicine
On Feb. 26, 2026, Novartis announced it has settled a lawsuit by the estate of Henrietta Lacks that…
-
MAP-Xing malaria protein complexes
On Dec. 12, 2025, an international research team headed by scientists from Nanyang Technological University, Singapore and the…
-
First Cases of Highly Pathogenic Avian Influenza in Northern Elephant Seals Confirmed in California
On Feb. 25, 2026, seven weaned elephant seal pups in California’s Año Nuevo State Park tested positive for…
-
Novartis settles 18-month-old lawsuit from estate of Baltimore woman whose cells were extracted 75 years ago
On Feb. 24, 2026, The family of a Baltimore woman whose cells were extracted for medical research without…
-
Researchers Borrow from biology to power next-gen data storage
On Feb. 24, 2026, a research team from the Pennsylvania State University (Penn State) show that DNA, the…
-
Baby boy first child born in the UK after mother transplanted with a womb from deceased donor
On Feb. 24, 2026, Womb Transplant UK announced in an historic breakthrough, that a bouncing baby boy has…
-
Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion
On Feb. 23, 2026, Gilead Sciences announced it will buy cancer therapy partner Arcellx for an implied equity…
-
in World first Lion DNA forensics secures historic conviction in Zimbabwe
On Feb. 20, 2026, for the first time anywhere in the world, DNA forensics has been used to…
-
CDC | Diagnostics | Infectious Disease | Measles | NIH | Vaccine
Report Details health and economic repercussions of declining MMR coverage in the U.S.
On Feb. 20, 2026, a research study lead by the Yale School of Public Health shows the resurgence…
-
Second $75 million gift from Phil and Penny Knight expands possibilities in care
On Feb. 19, 2026, Phil and Penny Knight announced they have given a second transformational gift of $75 million…
-
Biotechnology | CDC | COVID-19 | Diagnostics | Infectious Disease | NIH | Vaccine
CDC Reported 10,000–23,000 RSV deaths in 2025
On Feb. 19, 2026, the U.S. Centers for Disease Control and Prevention (CDC) reported severe outcomes from COVID-19…
-
Biotechnology | CDC | Diagnostics | Environmental | Infectious Disease | Measles | Vaccine
Oregon wastewater dashboard Confirms measles outbreak
On Feb. 19, 2026, a new data tracking tool Oregon Health Authority (OHA) has been launched that shows the five confirmed measles cases identified in the…
-
Merck and Mayo Clinic Announce R&D Collaboration Supporting AI-Enabled Drug Discovery and Precision Medicine
On Feb. 18, 2026, Merck, known as MSD outside of the U.S. and Canada, and Mayo Clinic, the…
-
Chemistry-Powered “Breathing” Membrane Opens and Closes Tiny Pores on Its Own
On Feb. 18, 2026, researchers at SANKEN, University of Osaka announced using a nanoreactor to produce pores that…
-
Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
On Feb. 18, 2026, Johnson & Johnson announced announced a more than $1 billion investment in a next…
